Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis
Evaluation of the Treatment of Symptomatic Proximal InterPhalangeal (PIP) Joint Osteoarthritis With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition
TBF Genie Tissulaire
14 participants
Oct 7, 2024
INTERVENTIONAL
Conditions
Summary
The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of PIP joint osteoarthritis.
Eligibility
Inclusion Criteria7
- Male or female; age between 18 and 75 years.
- Patient with symptomatic PIPJ OA.
- Patient treated medically for functional signs for more than 3 months, without improvement, justifying a surgical intervention.
- Patient with a QuickDash score \> 33 points (converted to 50%).
- Patient with pain, at rest, in the PIPJ ≥ 4/10 on a VAS.
- Patient who received the study information and provided consent.
- Member or beneficiary of a national health insurance plan.
Exclusion Criteria5
- Pregnant or breastfeeding woman; woman without effective contraception.
- Patient with signs of neuropathy with functional disorders such as hyperesthesia.
- Patient with uncontrolled epilepsy or neuropathy that contraindicates locoregional anesthesia.
- Person confined by a judicial or administrative decision.
- Adult subjected to legal protection measures or unable to provide his/her consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Decellularized, viro-inactivated, freeze-dried and sterile allogeneic graft of amniotic membrane of umbilical cord used as an interposition implant in the PIPJ
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06034262